Your session is about to expire
← Back to Search
Intracorporeal vs Extracorporeal Urinary Diversion for Bladder Cancer
Study Summary
This trial suggests that ICD provides superior postoperative outcomes compared to ECD, with less exposure to the external environment, less bowel-related complications, and lower pain scores.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had major surgery in my abdomen or pelvis that would prevent safe robotic surgery.I am between 18 and 99 years old.My cancer is in an early or locally advanced stage, or I have persistent carcinoma in situ.My surgeon thinks my lung condition could make surgery risky.I am unable to understand and give consent for treatment.My bladder cancer diagnosis was confirmed with a biopsy, and I am being considered for robotic surgery.I am scheduled for a robotic-assisted radical cystectomy as agreed with my surgeon.
- Group 1: Extracorporeal Urinary Diversion (ECD)
- Group 2: Intracorporal Urinary Diversion (ICD)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this medical research accept elderly individuals in its patient pool?
"As indicated in the eligibility criteria, this study seeks participants aged 18 to 99. Additionally, there are 9 studies that focus on those below the age of majority and 373 for patients above senior citizen status."
Are doctors currently seeking volunteers for this research?
"Affirmative. The information found on clinicaltrials.gov confirms that this trial is actively recruiting new participants and was first published on April 25th 2018, with the most recent changes being made on February 2nd 2022. A total of 88 individuals are needed from two different medical sites for this project to be completed successfully."
How many participants have been included in this trial thus far?
"Affirmative. Clinicaltrials.gov contains evidence that this trial, which first went live on April 25th 2018, is currently recruiting individuals for participation. The study requires 88 participants to be sourced from two different sites."
What demographic is eligible to enroll in this experimentation?
"The trial seeks individuals with bladder cancer, aged 18 to 99 years old. At present, 88 patients have been accepted into the study."
Share this study with friends
Copy Link
Messenger